CLINICAL STUDIES AT HOSPITAL OF CHONNAM NATIONAL UNIVERSITY, SOUTH KOREA
Experience of Acnotide – Antimicrobial Peptide
in topical treatment of patients with acne
The first clinical trial of AcnoCell products with granulisin-derived peptide GDP 20 was conducted at the National Jongnam Medical University of Korea.
29 patients, average age 22 years
All patients topically applied AcnoCell produst during 12 weeks and the results showed the effectiveness of products.
*А – Before treatment
B – 2 weeks after treatment
C – 4 weeks after treatment
D – 8 weeks after treatment
E – 12 weeks after treatment
The second clinical trial of AcnoCell products was conducted at the National Chunnam Medical University of Korea.
320 patients, the average age was 22.6 years
AcnoCell products was applied during 4 weeks, and acne improved in 80% of the patients compared to placebo without any side effects.
*At below photo, a military man of 22 years of age, full recovery of acne after 3 three-week use of AcnoCell products according to the protocol.
*At the below photo you can see the improvement skin condition of girl of 21 years old, whose skin worsened after applying inappropriate cosmetics and did not pass within 3 years. After using AcnoCell products during 3 weeks, the skin condition has noticeably improved.
*At below photo of a girl of 17 years old, the condition of acne improved after 2 weeks of using the products.
*At the below photo, a 40-year-old man, acne condition improved after 1 week of using the products.
*At below photo you can see the skin condition improvement of man of 24 year old after 3 weeks of usage products, provided by doctors from Indonesia
